Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 26, 2026, titled "Submission of press release that Eugia Pharma receives USFDA Approval for Everolimus Tablets.".
Press Release Feb 26 2026
Filed with NSE · · 3 pages · English
Release
Earlier from Aurobindo Pharma
- Press Release Feb 13 2026
- Press Release Feb 09 2026
- Kargo.ai Raises $42M Series B to Scale Global Warehouse Deployment with Enterprise Clients
- Press Release Nov 05 2025
- Press Release Aug 04 2025
Later from Aurobindo Pharma
- Press Release Mar 04 2026
- Press Release Apr 06 2026
- Press Release Apr 07 2026
- Press Release Apr 17 2026
- Press Release May 21 2026
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma